-
DE
GPR119 – Receptor, Function & Diabetes Research
GPR119 is a G protein-coupled receptor found primarily in the pancreas and intestine, playing a key role in regulating blood glucose levels and insulin secretion.
Add as Preferred SourceThings worth knowing about "GPR119"
GPR119 is a G protein-coupled receptor found primarily in the pancreas and intestine, playing a key role in regulating blood glucose levels and insulin secretion.
What is GPR119?
GPR119 (G protein-coupled receptor 119) is a membrane-bound receptor belonging to the large family of G protein-coupled receptors (GPCRs). It is predominantly expressed in the beta cells of the pancreas, the L-cells of the small intestine, and in the brain. GPR119 is considered an important pharmacological target in the development of novel therapies for type 2 diabetes and obesity.
Mechanism of Action
GPR119 is activated by endogenous lipid mediators, including oleoylethanolamide (OEA), lysophosphatidylcholine (LPC), and certain long-chain fatty acids and their derivatives. Upon activation, the receptor couples to the stimulatory G protein Gαs, leading to an increase in intracellular cAMP (cyclic adenosine monophosphate) levels. This triggers several important physiological effects:
- Glucose-dependent insulin secretion: In pancreatic beta cells, elevated cAMP levels stimulate insulin release, but only when blood glucose levels are elevated. This mechanism minimizes the risk of hypoglycemia.
- Incretin hormone release: In intestinal L-cells, GPR119 promotes the secretion of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These incretin hormones amplify insulin release and slow gastric emptying.
- Appetite regulation: Through the incretin axis and central mechanisms, GPR119 contributes to body weight reduction.
Medical Significance and Research
Due to its unique localization and function, GPR119 is an attractive target for the development of next-generation antidiabetic drugs. Unlike classical sulfonylureas, activation of GPR119 stimulates insulin secretion in a strictly glucose-dependent manner, significantly reducing the risk of dangerous hypoglycemic episodes.
Numerous preclinical and clinical studies have investigated GPR119 agonists (compounds that activate the receptor). Well-known experimental compounds include:
- MBX-2982
- GSK1292263
- APD597 (JNJ-38431055)
These substances have demonstrated moderate improvements in blood glucose control in Phase II clinical trials, although their efficacy compared to already approved antidiabetic agents still requires further optimization.
Natural Activators of GPR119
In addition to synthetic agonists, there are naturally occurring substances capable of activating GPR119:
- Oleoylethanolamide (OEA): A lipid mediator derived from oleic acid in the intestine, involved in satiety regulation.
- Lysophosphatidylcholine (LPC): A breakdown product of phospholipids that rises in the intestine after fatty meals.
- Long-chain fatty acids: Certain unsaturated fatty acids such as oleic acid can weakly activate GPR119.
Clinical Relevance and Outlook
GPR119 represents a promising but not yet clinically approved therapeutic approach. Further research into this receptor could lead to the development of novel, well-tolerated medications for patients with type 2 diabetes mellitus and obesity. Combination therapies, for example with DPP-4 inhibitors or GLP-1 receptor agonists, are also being investigated to exploit potential synergistic effects.
References
- Overton, H.A. et al. (2006): Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypoglycemic agents. In: Cell Metabolism, 3(3), 167-175.
- Flock, G. et al. (2011): Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice. In: Diabetes, 60(10), 2563-2571.
- World Health Organization (WHO): Global report on diabetes. Geneva, 2016. Available at: https://www.who.int/publications/i/item/9789241565257
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €